tiprankstipranks
Advertisement
Advertisement

BAT boosts strategic stake in Charlotte’s Web Holdings

Story Highlights
  • Charlotte’s Web secured a new C$13.9 million equity investment from BAT’s subsidiary at a minimum price of C$0.94 per share.
  • Amended debenture terms and investor rights will give BAT up to 40.8% ownership and significant governance influence while capping its stake below 49%.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
BAT boosts strategic stake in Charlotte’s Web Holdings

Claim 30% Off TipRanks

Charlotte’s Web Holdings ( (TSE:CWEB) ) has provided an update.

Charlotte’s Web Holdings, Inc. is a U.S.-based producer of hemp-derived wellness products, focused on cannabidiol (CBD) formulations for food, dietary supplements and related consumer health applications. The company targets regulated cannabis-adjacent markets and lists its common shares on the Toronto Stock Exchange and Nasdaq, positioning itself as a branded CBD platform for mainstream retail channels.

On March 30, 2026, Charlotte’s Web agreed to a C$13.9 million equity investment from British American Tobacco subsidiary BT DE Investments, alongside an amendment to a 2022 C$75.3 million convertible debenture that cuts the conversion price to C$0.94 and lifts BAT’s potential stake to about 40.8% on a non‑diluted basis. Upon an expected closing around May 28, 2026, BAT will immediately convert the debenture into roughly 95.3 million shares, gaining board nomination, pre‑emptive and minority‑protection rights under an amended investor rights agreement, while accepting standstill, lock‑up and ownership limits that cement it as a controlling strategic partner without crossing a 49% threshold.

The most recent analyst rating on (TSE:CWEB) stock is a Hold with a C$0.75 price target. To see the full list of analyst forecasts on Charlotte’s Web Holdings stock, see the TSE:CWEB Stock Forecast page.

Spark’s Take on CWEB Stock

According to Spark, TipRanks’ AI Analyst, CWEB is a Neutral.

The score is held down primarily by weak financial performance, driven by persistent losses, negative free cash flow, and a constrained balance sheet. Technicals provide a meaningful offset with a strong uptrend and positive momentum, while valuation remains unfavorable/limited due to ongoing losses and no dividend.

To see Spark’s full report on CWEB stock, click here.

More about Charlotte’s Web Holdings

Charlotte’s Web Holdings, Inc. is a U.S.-based producer of hemp-derived wellness products, focused on cannabidiol (CBD) formulations for food, dietary supplements and related consumer health applications. The company targets regulated cannabis-adjacent markets and lists its common shares on the Toronto Stock Exchange and Nasdaq, positioning itself as a branded CBD platform for mainstream retail channels.

On March 30, 2026, Charlotte’s Web agreed to a C$13.9 million equity investment from British American Tobacco subsidiary BT DE Investments, alongside an amendment to a 2022 C$75.3 million convertible debenture that cuts the conversion price to C$0.94 and lifts BAT’s potential stake to about 40.8% on a non‑diluted basis. Upon an expected closing around May 28, 2026, BAT will immediately convert the debenture into roughly 95.3 million shares, gaining board nomination, pre‑emptive and minority‑protection rights under an amended investor rights agreement, while accepting standstill, lock‑up and ownership limits that cement it as a controlling strategic partner without crossing a 49% threshold.

Average Trading Volume: 201,596

Technical Sentiment Signal: Buy

Current Market Cap: C$159.4M

Find detailed analytics on CWEB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1